AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Predictive Oncology Inc. Director's Dealing 2013

May 8, 2013

35106_dirs_2013-05-08_4453be6e-5566-415e-b78a-eea085d722f9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioDrain Medical, Inc. (BIOR)
CIK: 0001446159
Period of Report: 2013-05-06

Reporting Person: Herschkowitz Samuel (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-05-06	Common Stock, par value $0.01 per share	J	357163	—	Acquired	46342481	Direct

Footnotes

F1: On May 6, 2013, the principal amount of $51,243 and accrued interest thereon under the promissory note dated November 6, 2013, made by the Issuer in favor of Dr. Herschkowitz, was converted into 357,163 shares of the Issuer's Common Stock, par value $0.01 per share, representing a conversion price of $0.15 per share.